What the shift toward outcomes means for chiropractors, and why the practices that adapt first will lead
The most consistent feedback I hear from benefits leaders right now isn’t about cost. It’s about resolution.1
They know what they’re spending on musculoskeletal care, but what they can’t tell you is whether any of it is actually working.
Resolution is becoming the new currency in MSK care
That gap is what’s reshaping how MSK spending gets evaluated in 2026, and it has direct implications for every chiropractic practice in the US. For most of the last decade, the health plans and employers paying for MSK services were comfortable rewarding activity such as visit volume, engagement scores and member satisfaction surveys.
That era is closing. The question every chiropractor will face soon, if they aren’t already, is whether their practice can demonstrate something more rigorous, for example: Was the patient’s condition resolved in fewer visits than the industry average with fewer downstream claims?
What employers are asking now
Talk to any benefits leader spending real money on digital MSK programs in 2026, and you’ll hear the following same questions:
- Did the episode close?
- How long did it take?
- What happened downstream?
- Did imaging utilization drop?
- Did surgical referrals?
Digital engagement metrics used to be enough. Now they’re table stakes at best. A vendor that can tell an employer how many sessions a member completed but can’t answer whether the condition resolved is going to have a tough renewal conversation. With family premiums averaging close to $27,000 a year and projected to climb again in 2026, employers don’t have patience for activity dressed up as outcomes.2
What the evidence says works
There’s a substantial body of evidence on what high-value MSK care looks like, and the patterns are remarkably consistent:3
- Episodes are shorter.
- Imaging is used selectively.
- Surgical escalation is rare.
- Outcomes vary less from patient to patient.
The strongest signal in the literature points to early, guideline-adherent conservative care as the highest-leverage move in any MSK episode.4 A retrospective analysis of more than 3.7 million patients with low back pain found those whose initial provider was a chiropractor or physical therapist had significantly lower rates of receiving early opioid prescriptions and advanced imaging than those whose first stop was an emergency department or primary care office. The choice of front door changes the entire trajectory of the episode.
None of this means imaging or surgery is wrong. Both are essential when clinically indicated. But when conservative, hands-on care is the front door, fewer patients ever reach the expensive interventions, and the ones who do are the right ones.
The DC opportunity and the catch
On paper, chiropractors are ready for this moment. We’re already first-line MSK providers in the eyes of many patients. Our training emphasizes conservative, hands-on care. Our cost per episode is a fraction of what surgical or injection-based pathways generate. That’s the profile employers are increasingly looking for in a population health partner: a high-touch, low-cost entry point into the system that keeps people out of expensive escalation pathways.
The catch is that positioning doesn’t matter if the practice model doesn’t keep up. The chiropractors who win in this market will operate differently than most practices operate today. They’ll think in episodes, not visits. They’ll standardize their care pathways enough that outcomes stop varying patient to patient. They’ll define success by whether the condition is resolved, not by how many appointments were billed.
Outcome data is the new credibility
Payers and employers fund this care, and they have every right to ask what they’re getting for it.
If a practice can’t answer those questions with data, it can’t make its case. And data only carries weight if the clinical documentation behind it does. Functional outcome scores, pain ratings, treatment milestones and discharge notes need to be captured consistently and recorded cleanly.
Practices investing in outcome tracking that benchmark against population norms and present results clearly to health plans and employer benefits teams will hold a position that’s very hard to challenge. The ones that don’t will find themselves competing primarily based on price, which is a losing game in healthcare.
Key learning points
- MSK costs keep climbing because patients aren’t getting the right care first. Utilization is a symptom, not the disease.
- Employers and payers are reconsidering digital programs and buying engagement metrics. They want episode outcomes, total cost of care and downstream avoidance.
- Chiropractors have the clinical positioning to lead this shift, but the practice model has to change. Visit counts won’t cut it.
- Outcome data is becoming the price of admission. Practices that document resolution rates, episode duration and reduced escalation will have a clear edge.
Final thoughts: Where this is heading
Strip away the cost data, the contracting language and the population health framing for a moment. What employers and payers are really asking for is something patients have wanted all along: care that actually fixes the problem, in a reasonable amount of time, without sending them on a months-long tour of the healthcare system.
Chiropractors are unusually well-positioned to deliver exactly that. The challenge is proving it at scale, with documentation rigorous enough to stand up to a payer’s analytics team.
Chris Cato, DC, is chief population health officer at Airrosti, a muscle and joint pain healthcare group headquarted in San Antonio, Texas.
References
- Business Group on Health. 2025 Employer Health Care Strategy Survey. Washington, DC; 2024. https://www.businessgrouphealth.org/resources/2025-employer-health-care-strategy-survey-intro. Accessed May 11, 2026.
- Childs JD, et al. Implications of early and guideline adherent physical therapy for low back pain on utilization and costs. BMC Health Serv Res. 2015;15:150. https://pmc.ncbi.nlm.nih.gov/articles/PMC4393575/. Accessed May 11, 2026.
- Harwood KJ, et al. Where to start? A two-stage residual inclusion approach to estimating influence of the initial provider on health care utilization and costs for low back pain in the US. BMC Health Services Research. 2022;22(694). https://link.springer.com/article/10.1186/s12913-022-08092-1. Accessed May 11, 2026.
- Kaiser Family Foundation. 2025 Employer Health Benefits Survey. October 2025. https://www.kff.org/health-costs/2025-employer-health-benefits-survey/. Accessed May 11, 2026.
